Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of prevention after a cerebrovascular evenT (IMPACT) study

Stroke

Volumn 39, Issue 6, 2008, Pages 1834-1843

  Touzé, Emmanuel ^a   Coste, Joël ^b   Voicu, Magdalena ^a   Kansao, Jamal ^b   Masmoudi, Rafik ^c   Doumenc, Benoit ^d   Durieux, Pierre ^c   Mas, Jean Louis ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Cochin   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

Adherence; Guidelines; Hypertension; Secondary prevention; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; REINFORCEMENT; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; STROKE; BLOOD; BLOOD PRESSURE; CLINICAL PROTOCOL; COMORBIDITY; DRUG ANTAGONISM; DRUG EFFECT; FRANCE; HEALTH CARE DELIVERY; HOSPITAL; HOSPITALIZATION; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS;

AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; CHOLESTEROL, LDL; CLINICAL PROTOCOLS; COMORBIDITY; DELIVERY OF HEALTH CARE; FEMALE; FRANCE; HOSPITALIZATION; HOSPITALS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 46249111137     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.503094     Document Type: Article

References (38)

1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577- 617.
2. Touzé E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36:2748-2755.
3. Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology. 2000;54:1899-1906.
4. Amar J, Cambou JP, Touzé E, Bongard V, Jullien G, Vahanian A, Coppe G, Mas JL. Comparison of hypertension management after stroke and myocardial infarction: results from ECLAT1 - a French nationwide study. Stroke. 2004;35:1579-1583.
5. Arquizan C, Touzé E, Moulin T, Woimant F, Ducrocq X, Mas JL. Blood Pressure, smoking and oral contraceptive control after cryptogenic stroke in young adults in the PFO-ASA Study. Cerebrovasc Dis. 2005;20: 41-45.
6. Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention. The experience of a stroke clinic. Stroke. 1999;30: 16-20.
7. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002;33:1656-1659.
8. Touzé E, Mas JL, Rother J, Goto S, Hirsch AT, Ikeda Y, Liau CS, Ohman EM, Richard AJ, Wilson PW, Steg PG, Bhatt DL. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Stroke. 2006;37:2880-2885.
9. Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke. 2003;34:1010-1014.
10. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CDA. Antithrombotic and antihypertensive management 3 months after ische-mic stroke. A prospective study in an inner city population. Stroke. 2000;31:469-475.
11. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke. A prospective study. Stroke. 2001;32:1884-1889.
12. Touzé E, Cambou JP, Ferrieres J, Vahanian A, Coppe G, Leizorovicz A, Jullien G, Guerillot M, Herrmann MA, Mas JL. Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies. Cerebrovasc Dis. 2005;20: 78-84.
13. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8:iii-72.
14. Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001;39:II-46-II-54.
15. Grol R. Beliefs and evidence in changing clinical practice. BMJ. 1997; 315:418-421.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252.
17. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2748.
18. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294-316.
19. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999;30:1991-1994.
20. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531-536.
21. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Pancioli AM, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, Khoury J, Jauch E. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA. 1998;279:1288-1292.
23. Williams LS, Bruno A, Rouch L, Mariott DJ. Stroke patients knowledge of stroke. Influence on time to presentation. Stroke. 1997;28:912-915.
24. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, Janavs J, Dunbar G. The Mini International Neuropsychiatric Interview (MINI), a short diagnostic interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12:232-241.
25. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of non-adherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607-1612.
26. Agence Nationale d'Accréditation et d'Evaluation en Santé. Prise en charge des patients adultes atteints d'hypertension artérielle. Paris: Agence Nationale d'Accréditation et d'Evaluation en Santé; 2000.
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
28. Agence française de sécurité sanitaire des produits de santé. Prise en charge thérapeutique du patient dyslipidémique. Paris: Agence française de sécurité sanitaire des produits de santé; 2005.
29. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47: 345-351.
30. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825-834.
31. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
32. Touzé E, Saillour-Glenisson F, Durieux P, Verdier A, Leyshon S, Bendavid S, Attard T, Scheimann A, Mas JL, Coste J. Lack of validity of a French adaptation of a scale measuring attitudes towards clinical practice guidelines. Int J Qual Health Care. 2006;18:195-202.
33. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35:2879-2883.
34. Fonarow GC. The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes. Rev Cardiovasc Med. 2003;4(suppl 3):S37-S46.
35. Lang T. Social and economic factors as obstacles to blood pressure control. Am J Hypertens. 1998;11:900-902.
36. Manning G, Donnelly R. Use of home blood-pressure monitoring in the detection, treatment and surveillance of hypertension. Curr Opin Nephrol Hypertens. 2005;14:573-578.
37. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004; 329:145.
38. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet. 1997;349:454-457.